Is Viking Therapeutics, Inc. (VKTX) a Buy, Sell, or Hold?
NASDAQ : VKTX
Viking Therapeutics, Inc.
$37.08 USD
$0.71 (1.95%)
- Volume
- 1.92M
- Average Volume
- 2.42M
- Market Capitalization
- $4.31B
- P/E Ratio
- -8.96
- Dividend Yield
- 0.00%
- Price Target
- $95.00
- Year High
- $43.15
- Year Low
- $22.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.72
Analyst Consensus Summary
Consensus Rating
Strong Sell
24 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-61.0%
vs Current Price
Price Target
$95.00
Average TargetPrice Target Range
Lowest Target
$83.00
-55.3% DOWNSIDE
Average Target
$95.00
Median Estimate
Highest Target
$101.00
-63.3% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 24
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 1 | 22 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Truist Financial | Gregory Renza | $83 | $30.8 | 2026-05-27 06:08 AM | 169.5% |
| Cantor Fitzgerald | Steve Seedhouse | $100 | $31.33 | 2026-04-30 07:54 AM | 219.2% |
| Jefferies | Roger Song | $101 | $35.47 | 2026-03-12 12:48 PM | 184.7% |
| Morgan Stanley | Michael Ulz | $99 | $31.07 | 2026-02-12 08:16 AM | 218.6% |
| Canaccord Genuity | Edward Nash | $107 | $40.6 | 2025-11-12 06:43 AM | 163.5% |
| Canaccord Genuity | Edward Nash | $106 | $34.93 | 2025-10-29 05:33 AM | 203.5% |